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Abstract
Elevated QT interval variability (QTV) has been asso-
ciated with increased cardiac mortality, but the underlying
mechanisms are incompletely understood. Sympathetic ac-
tivity is thought to be a main contributor to QTV. The aim
of this study was to investigate the relation between car-
diac sympathetic integrity and QTV in 15 patients with
type 2 diabetes mellitus and varying degrees of cardiac
autonomic neuropathy. Cardiac sympathetic innervation
was assessed by 123I-mIBG scintigraphy based on heart-
to-mediastinum ratio of 123I-mIBG uptake 4 hours after
infusion. To assess QTV high resolution ECGs (1000 Hz)
were recorded during standing. Beat-to-beat QT inter-
vals were calculated over a period of 5 minutes, using a
template-stretching algorithm. QTV was quantified using
time and frequency domain measures as well as non-linear
approaches (symbolic dynamics, fractal dimension). The
group mean and standard deviation of HMR values were
1.07 ± 0.48. Time and frequency domain QTV parame-
ters were significantly increased in subjects with sympa-
thetic dysinnervation and inversely correlated with HMR
(r = −0.7, p < 0.001). In conclusion, there is a clear link
between sympathetic dysinnervation and elevated QTV in
patients with type 2 diabetes mellitus during sympathetic
activation. Sympathetic dysinnervation is associated with
increased ventricular repolarization lability.
1. Introduction
QT interval variability reflects temporal fluctuations in
the duration of ventricular repolarization. Elevated QT
variability has been associated with increased sudden car-
diac death risk in chronic heart failure [1] and ventricu-
lar arrhythmogenesis in patients with structural heart dis-
ease [2]. The origins of QT variability, particularly the
influences of autonomic nervous system activity, remain
incompletely understood. Acute elevation of QT vari-
ability has been observed in response to sympathetic ac-
tivation [3] and in disease states characterized by sympa-
thetic overactivity [1, 2]. Conflicting results on associa-
tions with cardiac norepinephrine spillover, the gold stan-
dard in assessment of cardiac sympathetic activity, have
been reported. Positive correlations were described in hy-
pertension [4] but not major depression/panic disorder [5].
The cardiac autonomic neuropathy (CAN) of type 2 di-
abetes mellitus (T2DM) is independently associated with
poor prognosis [6]. Vagal impairment of cardiac control
can be readily assessed by measuring heart rate variability
[7]. Sympathetic involvement in CAN may be identified
with high specificity by radionuclide imaging using the
tracer iodine 123-metaiodobenzylguanidine (123I-mIBG),
which shares the neuronal uptake and storage mechanisms
of norepinephrine. Reduced heart rate variability as well
as globally reduced cardiac uptake of 123I-mIBG, consis-
tent with vagal and sympathetic dysinnervation, have been
identified in patients with diabetes mellitus [6]. In a re-
cent study we reported negative correlations between car-
diac 123I-mIBG uptake and QT variability in patients with
T2DM, suggestive of an association between myocardial
sympathetic dysinnervation and repolarization lability. [8].
Importantly, this association was only observed during a
period of sympathetic activation (i.e. standing), but not
during rest. The aim of this study was to further identify
specific features of QT interval variability that might be
primarily reflective of sympathetic dysinnervation.
2. Methods
2.1. Subjects
Subjects with T2DM (n = 15) with no history of car-
diovascular disease, cancer or psychiatric or other severe
illness were recruited from the community (Table 1). 123I-
mIBG imaging and heart rate variability data for this co-
hort has been reported previously [9]. Exercise echocar-
diography studies were performed in all patients to verify
normal ejection fraction (> 50%) and the absence of coro-
nary artery disease (i.e. no inducible wall motion abnor-
malities indicative of ischemia). Patients provided written
informed consent and the study protocol was approved by
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Table 1. Patient characteristics.
Male [%] 60
Age [yrs] 57.9± 8.1
Diabetes duration [yrs] 7 [6-14]
HbA1c [mmol/mol] 8.2± 2.2
BMI [kg/m2] 30.2± 5.4
Heart rate [bpm] 71± 12
Systolic BP [mmHg] 125± 19
Diastolic BP [mmHg] 72± 9
Hypertension [%] 9
Heart-to-mediastinum ratio 1.84± 0.16
hospital and university human research ethics committees.
2.2. 123I-MIBG imaging
Protocols for recording and analysis of 123I-mIBG im-
ages have been described in detail [9]. Patients were pre-
medicated with 600 mg potassium perchlorate to block
thyroid uptake of radioiodine. A low-energy, high-
resolution collimator (Symbia, Siemens, Erlangen, Ger-
many) was used in the acquisition of anterior planar and
single photon emission computed tomography (SPECT; 32
projections for 50 s each) images 15 minutes (early) and
4 hours (delayed) following injection of 150 MBq of 123I-
mIBG. Global cardiac uptake of 123I-mIBG was calculated
from both early and delayed planar images by the ratio of
tracer activity (mean count per pixel) in the heart and me-
diastinum. Due to non-neuronal uptake affecting early im-
ages, the delayed heart-to-mediastinum ratio (HMR) was
primarily used in analyses and to define the presence of
cardiac sympathetic dysinnervation (HMR < 1.8) [10].
2.3. ECG recording and QT variability
analysis
Studies were performed in accordance with standard
conditions for clinical autonomic testing. Subjects were
assessed in the morning and following a light meal and ad-
ministration of diabetes medications. Pre-test abstinence
from smoking and caffeine (12 hours), and alcohol, heavy
exercise and anti-hypertensive medications (24 hours) was
required. Following at least 20 minutes supine rest in a
quiet room, an ECG (lead II) was recorded continuously
over 5-minutes during standing at a sampling frequency
of 1kHz using a Powerlab 8SP data acquisition system
linked with commercially available software (LabChart
Pro v6.1.3, AD Instruments, Sydney, Australia). After vi-
sual inspection of all ECG recordings to remove artifacts,
beat-to-beat QT intervals were calculated using the algo-
rithm proposed by Berger et al [1]. Here, an operator-
defined QT interval template is selected for one beat based
Table 2. QT variability measures.
meanQT mean QT interval duration, in s
sdQT standard deviation of QT intervals, in s
RMSSD RMS of QT interval differences, in s
LF low frequency power, in s2
HF high frequency power, in s2
DH Higuchi’s fractal dimension
0V words with zero variation, in %
1V words with one variation, in %
2LV words with 2 likewise variations, in %
2ULV words with 2 unlike variation, in %
on the beginning of the QRS complex and the beginning
and end of the T wave. The algorithm then calculates the
QT intervals of all other beats by determining the degree
to which the template must be stretched or compressed in
time to optimally match each T wave. In contrast with al-
ternative methods, consideration of the whole T wave en-
ables a relatively robust estimation of beat-to-beat QT in-
terval changes. Of the beat-to-beat QT interval time series
we computed the measures summarized in Table 2.3.
Time and frequency domain measures were computed
according to the Heart Rate Variability Task Force guide-
lines [11]. To compute the fractal dimension DH of
a graph, Higuchi considers a finite set of observations
X(j), j = 1, 2, ..., N taken at a regular interval k, and
evaluates the length Lm(k) of the corresponding graph
for different interval lengths k from sequences Xkm :
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If the behaviour of the graph has fractal characteristics over
the available range k then
L(k) ∝ k−DH , (2)
where DH is the fractal dimension and L(k) is the aver-
age value over k partial lengths of the graph. For a straight
line, DH = 1. For Brownian motion, DH = 1.5, and
for Gaussian white noise, DH saturates at two. For time
series with 1/fβ power spectra, DH = (5 − β)/2. This
relationship is valid for 1 < β < 3. Numerical exper-
iments have shown that time series with the same β can
show different DH values depending on the phase distri-
bution [12]. We have previously employed Higuch’s frac-
tal dimension to measure the roughness of R-R time series
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[13]. For symbolic analysis of QTV we employed the ap-
proach proposed by Porta et al. [14]. Time series of QT
intervals were transformed into an alphabet of 6 symbols
0, 1, 2, 3, 4, 5. As a transform rule nonuniform quanti-
zation was applied, keeping constant the number of points
associated with each quantization level. All the patterns
(symbolic sequences) with a length of three were grouped
into four families according to the number and types of
variations from one symbol to the next. The pattern fami-
lies are: 1) patterns with no variation (0V—all three sym-
bols are equal); 2) patterns with one variation (1V—two
consecutive symbols are equal and the remaining one is
different); 3) patterns with two like variations (2LV—the
three symbols form an ascending or descending ramp), 4)
patterns with two unlike variations (2ULV—the three sym-
bols form a peak or a valley).
2.4. Statistics
For statistical analysis we computed mean values and
standard deviations of QTV measures as well as 123I-
mIBG markers. To investigate the relationship between
QTV measures and cardiac sympathetic dysinnervation,
we computed Pearson’s correlation coefficients.
3. Results
Patients displayed a wide range of cardiac 123I-mIBG
uptake, ranking from normal (HMR > 1.8; n = 9) to
abnormal (HMR < 1.8; n = 5). Measures of QTV are
displayed in Table 3 subdivided based on presence of sym-
pathetic dysinnervation (Table3) All time and frequency
domain measures indicate elevated QTV in patients with
sympathetic dysinnervation. Non-linear measures, which
assess the complexity rather than the magnitude of QTV
show no significant group differences Pearson’s correla-
tion coefficients as indicated in the last column of Ta-
ble 3 show a similar degree of correlation between all QTV
time and frequency domain measures and HMR around
r = 0.7, with the exception of HF. None of the complexity
measures shows a significant correlation with HMR.
4. Discussion and conclusions
The main finding of our study is that magnitude rather
than complexity of beat-to-beat QT interval variability
elicited by sympathetic activation is associated with sym-
pathetic dysinnervation. Time and frequency domain anal-
ysis of QTV suggest a lack of a specific frequency range
being primarily responsible for this association. Assess-
ment of QTV complexity and its lack of association with
123I-mIBG uptake further suggests that there is no specific
temporal pattern of QTV indicative of sympathetic dysin-
nervation. In a recent study we investigated temporal dy-
Table 3. Group means and standard deviations of QT vari-
ability measures in patients with normal sympathetic in-
nervation (T2DM+) and with sympathetic dysinnervation
(T2DM-), t-test p-values as well as Pearson’s correlation
coefficient r with HMR.
T2DM+ T2DM- p r
meanQT 356.2± 33.2 378.0± 33.2 0.16 -0.38
sdQT 3.6± 0.8 6.7± 0.8 0.02 -0.75
RMSSD 2.9± 1.4 7.7± 1.4 0.01 -0.77
LF 0.9± 0.4 4.6± 0.4 0.01 -0.71
HF 1.4± 1.1 5.4± 1.1 0.07 -0.57
DH 1.9± 0.1 2.0± 0.1 0.09 -0.33
0V 32.9± 14.6 25.1± 14.6 0.30 0.23
1V 39.5± 4.7 42.0± 4.7 0.32 -0.19
2LV 4.3± 3.5 6.2± 3.5 0.45 -0.26
2ULV 23.3± 9.2 26.7± 9.2 0.43 -0.13
namics of QTV by means of detrended fluctuation analysis
and multiscale entropy and observed no long-range corre-
lations and multiscale entropy patterns, which were similar
to those of random data [15]. Despite the close physiologi-
cal relationship between average heart rate and average QT
interval, temporal short-term dynamics differ notably, the
latter being more erratic. With regard to sympathetic in-
volvement in the generation of QTV, our current findings
point towards a rather non-specific association.
Our data support the hypothesis that QT variability
reflects sympathetic function in the context of acute or
chronic sympathetic activation, as with standing, selective
pharmacological intervention, or disease. However, 123I-
mIBG scintigraphy is not synonymous with measuring
sympathetic activity per se, but instead reflects the holistic
integrity of postganglionic presynaptic sympathetic nerve
terminals, including norepinephrine uptake, storage and
release mechanisms [16]. Indeed, the dysinnervation iden-
tified by low HMR in our patients may relate to structural,
rather than functional defects, characterized by anatomical
neuronal loss (i.e. denervation).
In conclusion, there is a clear link between sympathetic
dysinnervation and elevated QTV in patients with type 2
diabetes mellitus during sympathetic activation. Sympa-
thetic dysinnervation is associated with increased ventric-
ular repolarization lability.
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